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W e report on a double immunofluorescence staining for the 
detection of the Langerhans Cell (LC) population in S-phase. 
After trypsinization, the epidermal cel l suspensions were 
enriched for LC and exposed to 10 ,11M BrdU for 2 h. Studies 
of BrdU labeled ce lls included the determination of their cel l 
surface phenotype. Both membrane labeling and incorpo-
rated BrdU as revealed using anti-BrdU demonstrated the 
T he Langerhans cells (LC) are migratory bone marrow-derived dendritic cells with a specific intracytoplas-mic organelle, the Birbeck granule. They express HLA-DR (MHC-class II) molecul e, and thereby, an-tigen-presenting cells represent the major accessory 
cells of Skin Associated Lymphoid Tissue (SALT) [1 -3]. The T6 
antigen, a common antigen expressed by LC and the cortical thy-
mocytes, is a frequently used surface marker for the study of epider-
mal LC in human skin [4 - 6]. LC comprise 2% - 4% of all epidermal 
ce ll s [1]. 
P revious studies based on [3H] Thymidine incorporation [7 ,8J 
into the nucl ei reported LC in S-phase but, in th ese studies, the 
identification of LC was uncerta in because they were not identified 
by immunologic markers. More recently , immunocytochemical 
studies have shown that the number of LC was increased in certain 
pathologic conditions [9,10]' but in these cases the presence of ce ll s 
in S-phase or mitosis was not proved. Thus far , on ly one study has 
been published where the authors eva luated the LC replication po-
tentia l in human skin grafted on nude mice. Mice bearing two-
lTIonth old human skin grafts were injected with BrdU and the 
incorporated BrdU and LC were revea led at the same time on skin 
sections using Fluorescein isothiocyanate (FlTC) conju gated anti-
BrdU and OKT6 monoclonal antibodies (Mab) [11]. 
W e report here the detection of repl icating LC performed di-
rectly on epidermal cell suspensions from normal human skin. W e 
d e fine BrdU incorporation staining and fixation conditions en-
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presence of LC in S-phase. We observed 6% of the epidermal 
LC in S-phase. This is a proof that LC are able to proliferate 
in the epidermal microenvironment. This technique, besides 
being rapid and free of radioactivity, allows the cytokinetic 
study of phenotypically defined LC in heterogeneous epider-
nul cell populations. ] bwest D ermato/ 91 :603 - 605, 1988 
abling the simultaneous detection of nuclear BrdU and surface anti-
gen on epidermal LC in suspension. 
MATERIALS AND METHODS 
Epidermal LC Cell suspensions were obtained by trypsinization 
of human normal skin specimens taken during plastic surgery, as 
described in (1 2). LC enrichment was obtained by Ficoll-Hypaque 
(Pharmacia, France) sedimentation [1 2]. 
In Vitro BrdU Incorporation Enriched-LC suspensions were 
incubated for 2 h at 37"C in MEM containing 10% Fetal Calf 
Serum (FCS) and BrdU at a fin al concentra tion oflO f.1M . After two 
washes in MEM-5%FCS, the cells were resuspended at 1 X 106 
ce ll slml. 
Simultaneous Cell Surface and Nuclear Staining The cells 
were stained for specific membrane antigen usin,g the Mab OKT6 
(Ortho , Raritan, NJ) fo llowed by biotinylated F(ab')z goat anti-
mouse IgG (Immunotech, Luminy, France) for 30 min at 4°C. The 
antibody- was revealed by rhodamine-conjugated avidin (Vector, 
Burlingame, CA) for an additional 30 min at 4 ° C. The pellet was 
washed twice in Phosphate buffered saline (PBS)-l % glucose and 
fi xed in 70% ethanol for 30 min at 4 ° C. The cells were then treated 
by 2N hydrochloric acid (HCI) for 30 min at 20°C. The acid was 
neutralized in 0.1 M Borax (pH 8.5) for 5 min and the cel ls were 
washed in PBS. 
The incorporated BrdU was revealed by a monoclonal antibody 
anti-BrdU (Becton Dickinson, Mountain View, CA) at a 1/10 dilu-
tion in PBS containing 0.5% Tween 20 and 10% Bovin Serum 
Albumin (BSA) for 30 min at 20°C. After two washes in 
PBS-10%BSA, the intranucl ear label was revealed by FITC-conju-
gated F(ab')2 goat anti-mouse IgG (Zymed, San Francisco, CA) for 
30 min at 20°C. After two washes in PBS-l0%BSA, cells were 
observed under a Zeiss Orthoplal1lTlicroscope with selective excita-
tion filters for fluorescein and rhodamine. Controls were performed 
in the absence of either OKT6 staining or anti-BrdU treatment. 
RESULTS 
In epidermal cel l suspensions fractioned by Ficoll-Hypaque sedi-
mentation, LC accounted for approximately 20%. LC-enriched 
cells were then distributed into 106 cells per assay. 
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Figure 1. Langerhans ce lls double labeled with OKT6 revealed in A by 
biotin-avidin rhodamine and with anti-UrdU revea led in B by FITC. ln this 
fi eld one LC (OKT6 +) has entered the S phase as revealed by the nuclear 
staini ng with the anti-BrdU (X 500). 
F ig ure 2. A differe nt LC suspension treated as in Fig 1. Note the reni form 
shape of the nucleus. (X 500). 
T HE J O URNAL OF INVESTIGATIVE DERMATOLOGY 
T able I. Simultaneous Analysis of Cell Surface Antigen and 
BrdU Incorporation of Epidermal LC. 
Skin samples' 
2 3 4 5 6 
DrdU+ T6+b 
(percentage) 
6.0 6.1 5.8 5.5 7.5 6.0 
~ T he assay was performed o n six di fferent skin specimens. 
b Mean percentage on 1000 counted cell s in randoml y chosen ficlds for each skin 
sample. 
T he cells positive for T 6 anti gen exhibited a bright red fluores-
cence confined to the cell surface membrane and the labeling had a 
fine granular aspect (Fig 10 and 2a). 
The nucl ei positive for BrdU showed a bright green fluorescence 
(Fig 1 b) . A reniform shape of the nucleus (known to be characteris-
tic of LC) could be observed (Fig 2b) . No labeling was observed in 
the cytopl asm. 
B rdU incorporation ranging from 30 min to 6 h were tested. It 
was found th at constant results were obtained after an incorporating 
time of 2 h or more. T wo hours was then chosen as the time of 
incorporation in our study. . 
Six different skin specimens were tested and a mean of 6% (5.5 to 
7.5%) of th e T 6 positive cells were also found to be BrdU positive 
(Table I) . This is a mea n percentge on 1000 counted cells in ran-
doml y chosen fields for each skin sample. Some BrdU positive and 
T6 negative cell s were observed. These cells corresponded to basal 
keratinocytes. Controls were negative indicating the specificity of 
the reaction. 
DISCUSSION 
In previ ous studies, th e proliferation activity of the LC was es tab-
lished on skin sections by tritiated thymidine incorporation [7,8]. 
Though the labeling indices observed were low (0.1 25%), these 
fi ndin gs showed that LC can pro life rate in normal skin. The low 
percentage (2%-4%) in normal skin and the low labeling index of 
LC represent £1ctors limiting the study of their cell cycle. 
Recently, a method for the evaluation of th e LC potential replica-
tion in epidermis was reported by Czernielewski et al [11] . They 
grafted normal human skin ollllude mice and after 2 months, grafts 
were used to estimate the LC in S-phase. BrdU was ir0ected in mice 
and then skill sections were taken at various times . Under these 
conditions, th e LC in S-phase was estimated to be 4.9% in normal 
skin . T hough this method appears reliable, it is not easy to perform 
because it requires the technology of skin graftin g on mice and is 
also time consumin g because it takes 2 months before any valid 
resul t ca n be obtained. 
W e have developed an easy and short method th at can be applied 
to epidermal cell s in suspension. By an in vitro tes t performed on a 
LC-enriched epidermal populations, we found 6% of LC in S-
phase. T hese results are consistent w ith those obtained by Czernie-
lewski et al [11]. T he method, described here, is rapid, specific, and 
does not involve radioactivity. Since LC account for 2% to 4% in 
normal epidermis, enrichment was performed to facilitate the study. 
T he number of LC was th ereby increased up to 20%, but this en-
richment does not allow subpopulations of LC to be selected [1 2]. 
T his enrichment provides possibilities of testin g the potential repli-
cation of LC from small specimens of skin. The conditions of en-
richment and a three-step monoclonal antibody biotin-avidin rho-
damine technique were necessary to detect a small cell population. 
The specificity of th e intranucl ear BrdU and membrane antigen 
labelings was very well preserved. Background staining was absent. 
This meth od offers the possibil ity to obtain a number of rapid and 
va luab le ins ights in to the cell kinetics ofLC in normal as well as in 
path ologic situations. Several studies have shown increased mitotic 
acti vity of LC after physical damage (UV light irradiation [1] or tape 
stripping [1 3] in burns [1 4]) or during pathol ogic processes includ-
ing histiocytosis X [1], mycosis fUl1 goides [9], squamous cell carci-
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norna , and seborrheic keratosis [10]. These studies using autoradiog-
raphy and cytochemistry suffer from the uncertainty of LC 
identification at the light microscope level. 
This in vitro test represents a specific, sensitive, and rapid method 
to establish the proliferative activity ofLC. It can be used to investi-
gate the influence of chemical products on LC kinetics in normal 
skin. 
Finally, our data demonstrate that LC are cycling and that they 
are a stable, self-reproducing cell population in normal human epi-
dermis. The presence ofLC in Sand G2/M phases was also demon-
stra t ed using fl ow cytometry-DNA measurement [15], but the con-
taminating keratinocytes could influence the results. The method 
described here also offers the possibility of a more precise and reli-
able analysis of the cell cycle of LC using flow cytometry. 
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